مباشر

Endpoints NewsRA, Forbion and Sanofi Ventures appear to back new eye drug from Korea Endpoints NewsNovocure’s electric fields therapy fails key glioblastoma study PharmaVoiceAs M&A rebounds, here’s how pharmas can prepare to seal a deal FierceBiotechKardigan buttons up $400M upsized IPO to power heart drugs toward phase 3 FierceBiotechNovocure device fails to improve brain cancer patients’ survival in phase 3 test FierceBiotechNortiva purrs into action with long-acting Lynx platform salvaged from Langer startup Endpoints NewsInnoviva revives Lyndra's long-acting oral drug platform FierceBiotechBiogen inks $1B RayThera buyout to bag preclinical immunology assets Endpoints NewsModerna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs Endpoints NewsEli Lilly's TuneLab hits 100 members, adding Chai's AI models CellChloroplast sunscreening by protein condensates confers high-light tolerance PharmaVoiceA new Westlake-backed biotech takes aim at migraines

Endpoints News ١٨ يونيو ٢٠٢٦

Moderna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs

→ In preparation for potential new product launches, Moderna has selected Ester Banque as chief commercial officer and expanded the role of president Stephen Ho...

→ In preparation for potential new product launches, Moderna has selected Ester Banque as chief commercial officer and expanded the role of president Stephen Hoge. Banque was head of US operations at Zoetis, and before ...